Page last updated: 2024-12-08

1-amino-9,10-dioxo-4-(3-sulfamoylanilino)anthracene-2-sulfonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

You're describing a complex organic molecule with a rather lengthy and specific name. It's likely you are referring to **Amido Black 10B**, a dye commonly used in **electrophoresis**.

Here's a breakdown of the molecule and its importance:

**1-Amino-9,10-dioxo-4-(3-sulfamoylanilino)anthracene-2-sulfonic acid**

* **Anthracene:** The core structure of the molecule is an anthracene ring, a planar polycyclic aromatic hydrocarbon.
* **Sulfonic acid groups:** Two sulfonic acid groups (-SO3H) are attached to the anthracene ring, making the molecule water-soluble.
* **Amino group:** An amino group (-NH2) is located at position 1 on the anthracene ring.
* **Sulfamoyl group:** A sulfamoyl group (-SO2NH2) is attached to an aniline (C6H5NH2) group, which is further attached to the anthracene ring at position 4.
* **9,10-dioxo:** This indicates the presence of two carbonyl groups (C=O) at positions 9 and 10 of the anthracene ring, making it a quinone derivative.

**Importance in Research:**

Amido Black 10B, due to its chemical structure and properties, plays a crucial role in **protein visualization during electrophoresis**:

* **Strong binding:** The dye has a high affinity for proteins, particularly basic amino acids like lysine and arginine. This strong binding allows for effective staining of protein bands on gels.
* **High contrast:** Amido Black 10B produces a dark blue-black color when bound to proteins, providing clear visual distinction between stained bands and the gel background.
* **Versatility:** It can be used with various electrophoresis techniques, including SDS-PAGE and native PAGE, making it a widely applicable reagent.

**Other Applications:**

Besides its primary role in protein staining, Amido Black 10B has also been used in other research areas like:

* **Histology:** For staining tissues and cell structures.
* **Analytical chemistry:** As a colorimetric reagent in assays.

**In summary,** 1-amino-9,10-dioxo-4-(3-sulfamoylanilino)anthracene-2-sulfonic acid, more commonly known as Amido Black 10B, is a valuable tool for researchers, particularly in the field of molecular biology and protein analysis, due to its strong protein binding and high contrast staining properties.

1-amino-9,10-dioxo-4-(3-sulfamoylanilino)anthracene-2-sulfonic acid: inhibits PH domain leucine-rich repeat protein phosphatase; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID272572
CHEMBL ID471225
SCHEMBL ID2781947
MeSH IDM0551427

Synonyms (27)

Synonym
1-amino-4-(3-(aminosulfonyl)anilino)-9,10-dioxo-9,10-dihydro-2-anthracenesulfonic acid
PROBES1_000352
NCGC00014173
PROBES2_000019
nsc-117079
nsc117079 ,
1-amino-9,10-dihydroanthracene-2-sulfonic acid
NCI117079
NCI60_000393
NCISTRUC1_001556
NCISTRUC2_001807
NCGC00097282-01
1-amino-9,10-dioxo-4-(3-sulfamoylanilino)anthracene-2-sulfonic acid
CHEMBL471225 ,
bdbm50328821
1-amino-9,10-dioxo-4-(3-sulfamoylphenylamino)-9,10-dihydroanthracene-2-sulfonic acid
1-amino-9,10-dioxo-4-(3-sulfamoylphenylamino)-9,10-dihydroanthracene-2-sulfonamide
CCG-37277
NCGC00014173-02
1-amino-9,10-dioxo-4-[(3-sulfamoylphenyl)amino]-9,10-dihydroanthracene-2-sulfonic acid
SCHEMBL2781947
500363-63-3
CS-0016845
HY-19819
A16894
MS-28769
AKOS040733876
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (32)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency4.08710.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency4.08710.025120.237639.8107AID886; AID893
15-lipoxygenase, partialHomo sapiens (human)Potency2.51190.012610.691788.5700AID887
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency8.91250.011212.4002100.0000AID1030
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency0.63100.00137.762544.6684AID914; AID915
cytochrome P450 2C19 precursorHomo sapiens (human)Potency3.98110.00255.840031.6228AID899
cytochrome P450 2C9 precursorHomo sapiens (human)Potency3.16230.00636.904339.8107AID883
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency3.98110.001815.663839.8107AID894
mitogen-activated protein kinase 1Homo sapiens (human)Potency7.94330.039816.784239.8107AID995
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency7.94330.031610.279239.8107AID884; AID885
lethal factor (plasmid)Bacillus anthracis str. A2012Potency0.02510.020010.786931.6228AID912
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency3.16230.316212.765731.6228AID881
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency3.16230.00638.235039.8107AID881; AID883
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency7.94331.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)IC50 (µMol)37.00000.20005.066710.0000AID1260080; AID1260081; AID1260082
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)IC50 (µMol)37.00000.20005.066710.0000AID1260080; AID1260081; AID1260082
PH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)IC50 (µMol)4.00004.00004.00004.0000AID525943
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (35)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adenylate cyclase-activating dopamine receptor signaling pathwayGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
fibroblast proliferationGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
cellular response to prostaglandin E stimulusGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
cellular response to catecholamine stimulusGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
signal transductionGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
adenylate cyclase-activating dopamine receptor signaling pathwayGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
G protein-coupled acetylcholine receptor signaling pathwayGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
Ras protein signal transductionGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
cell population proliferationGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
sensory perception of tasteGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
retina development in camera-type eyeGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
cellular response to prostaglandin E stimulusGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
cellular response to catecholamine stimulusGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
hippocampus developmentPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
signal transductionPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
protein dephosphorylationPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
G-protein beta-subunit bindingGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
GTPase activityGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
protein bindingGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
protein-containing complex bindingGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
GTPase bindingGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
signaling receptor complex adaptor activityGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
protein bindingPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
myosin phosphatase activityPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
metal ion bindingPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
protein serine/threonine phosphatase activityPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
membraneGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
extracellular exosomeGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
heterotrimeric G-protein complexGuanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
lysosomal membraneGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
cytosolGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
plasma membraneGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
membraneGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
synapseGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
extracellular exosomeGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
photoreceptor disc membraneGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
extracellular vesicleGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
heterotrimeric G-protein complexGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
cytoplasmGuanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
photoreceptor inner segmentPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
nucleoplasmPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
cytoplasmPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
cytosolPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
photoreceptor outer segment membranePH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
intercellular bridgePH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
mitotic spindlePH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
cytoplasmPH domain leucine-rich repeat-containing protein phosphatase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID526059Inhibition of PHLPP expressed in Cos7 cells assessed as increase of EGF-induced Akt phosphorylation on Ser473 at 50 uM after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525949Inhibition of PP2Calpha at 100 uM2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525943Inhibition of PHLPP2 phosphatase domain expressed in Escherichia coli2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID393936Antibacterial activity against Escherichia coli 1411 after 18 hrs by broth microdilution method2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
AID525945Inhibition of protein phosphatase 1 at 10 uM2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525939Inhibition of PHLPP in human HT20 cells assessed as increase of phosphorylation of GSK3 alpha/beta on Ser21/9 at 100 to 250 uM after 24 hrs by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID393933Inhibition of Escherichia coli MurF assessed as residual activity at 250 uM by malachite green assay2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
AID525952Inhibition of PHLPP expressed in 24 hrs serum starved Cos7 cells assessed as half maximal increase of phosphorylation on Ser473 after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525947Inhibition of PP2Calpha at 10 uM2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525944Inhibition of PHLPP in human HT20 cells assessed as increase of phosphorylation of Akt on Ser 473 at 100 to 250 uM after 24 hrs by immunoblotting relative to control2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525948Inhibition of protein phosphatase 1 at 100 uM2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525956Inhibition of PHLPP expressed in Cos7 cells assessed as increase of Akt phosphorylation on Ser473 at up to 120 uM after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525951Inhibition of PHLPP expressed in 24 hrs serum starved Cos7 cells assessed as increase of Akt phosphorylation on Thr308 at up to 120 uM after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID526061Cytoprotective activity against etoposide-induced cell death in african green monkey COS7 cells at 50 uM after 24 hrs by trypan blue exclusion assay2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID526060Inhibition of PHLPP expressed in Cos7 cells assessed as increase of EGF-induced Akt phosphorylation on Thr308 at 50 uM after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525953Inhibition of PHLPP expressed in 24 hrs serum starved Cos7 cells assessed as half maximal increase of phosphorylation of Akt substrate after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525937Inhibition of PHLPP2 phosphatase domain expressed in Escherichia coli at 10 uM2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525938Inhibition of PHLPP in human HT20 cells assessed as increase of phosphorylation of FoxO1/3alpha on Thr 24/32 at 100 to 250 uM after 24 hrs by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID525950Inhibition of PHLPP expressed in 24 hrs serum starved Cos7 cells assessed as increase of Akt phosphorylation on Ser473 at up to 120 uM after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID393937Antibacterial activity against AcrAB deficient Escherichia coli SM1411 after 18 hrs by broth microdilution method2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
AID525954Inhibition of PHLPP expressed in 24 hrs serum starved Cos7 cells assessed as half maximal increase of phosphorylation on Thr308 after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID699026Inhibition of HIV1 [32P]-labeled SL3 RNA interaction with NCp at 1mM after 1 hr by electrophoretic gel mobility shift assay2012Journal of medicinal chemistry, May-10, Volume: 55, Issue:9
Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.
AID525946Inhibition of protein phosphatase 2B at 10 uM2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID393938Antibacterial activity against Staphylococcus aureus 8325-4 after 18 hrs by broth microdilution method2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
AID525955Inhibition of PHLPP expressed in 24 hrs serum starved Cos7 cells assessed as increase of Akt phosphorylation after 30 mins by immunoblotting2010Journal of medicinal chemistry, Oct-14, Volume: 53, Issue:19
Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.79 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]